Directors

David Baltimore, Ph.D.

Professor of biology at the California Institute of Technology
and the recipient of the 1975 Nobel Prize in Physiology or Medicine

Bruce Carter, Ph.D.

Former President and CEO of Zymogenetics, Inc. and current Board member of additional biotechnology companies and scientific organization

Mark G. Foletta

Former Senior Vice President, Finance and Chief Financial Officer
of Amylin Pharmaceuticals, Inc.

John Maraganore, Ph.D.

Chief executive officer of Alnylam Pharmaceuticals

Stelios Papadopoulos, Ph.D.

Co-founder of several biotechnology companies
and former vice chairman of Cowen & Company

B. Lynne Parshall, Esq.

Director, chief operating officer and chief financial officer of Isis Pharmaceuticals

William H. Rastetter, Ph.D.

Former Chief Executive Officer of IDEC Pharmaceuticals

Douglas E. Williams, Ph.D.

Executive Vice President of Research and Development at Biogen Idec

Kleanthis G. Xanthopoulos, Ph.D.

President and chief executive officer of Regulus Therapeutics